相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature
Theo F. J. Kraus et al.
BRAIN TUMOR PATHOLOGY (2022)
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
Dorothee Hoelzl et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival
Lauren R. Schaff et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature
Theo F. J. Kraus et al.
BRAIN TUMOR PATHOLOGY (2020)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
Michael Rose et al.
ONCOGENE (2020)
Challenges to curing primary brain tumours
Kenneth Aldape et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Zane Jaunmuktane et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Defining EGFR amplification status for clinical trial inclusion
Pim J. French et al.
NEURO-ONCOLOGY (2019)
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A. Bale et al.
NEURO-ONCOLOGY (2019)
RnBeads 2.0: comprehensive analysis of DNA methylation data
Fabian Mueller et al.
GENOME BIOLOGY (2019)
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
David Capper et al.
ACTA NEUROPATHOLOGICA (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2018)
Updates in prognostic markers for gliomas
Elisa Aquilanti et al.
NEURO-ONCOLOGY (2018)
Anti-angiogenic therapy for high-grade glioma (Review)
Malaka Ameratunga et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer
Alejandro Aviles-Salas et al.
ONCOLOGY LETTERS (2017)
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Ping Wee et al.
CANCERS (2017)
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas
Martin J. van den Bent et al.
NEURO-ONCOLOGY (2015)
Emerging treatment strategies for glioblastoma multiforme
Steven K. Carlsson et al.
EMBO MOLECULAR MEDICINE (2014)
Role of Epidermal Growth Factor Receptor Signaling in the Interaction of Neisseria meningitidis with Endothelial Cells
Heiko Slanina et al.
INFECTION AND IMMUNITY (2014)
Comprehensive analysis of DNA methylation data with RnBeads
Yassen Assenov et al.
NATURE METHODS (2014)
Epidermal growth factor, from gene organization to bedside
Fenghua Zeng et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial
Monika E. Hegi et al.
ACTA NEUROPATHOLOGICA (2012)
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
Philip C. De Witt Hamer
NEURO-ONCOLOGY (2010)
Epigenetic Deregulation of DNA Repair and Its Potential for Therapy
Monika E. Hegi et al.
CLINICAL CANCER RESEARCH (2009)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents
Bernd Kaina et al.
DNA REPAIR (2007)
MGMT methylation status: The advent of stratified therapy in glioblastoma?
Peter Hau et al.
DISEASE MARKERS (2007)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
